Trial Profile
Desvenlafaxine (Pristiq) vs. Placebo in the Treatment of Chronic Depression.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Desvenlafaxine (Primary)
- Indications Depressive disorders; Dysthymic disorder
- Focus Therapeutic Use
- 07 Sep 2017 Status changed from recruiting to completed.
- 01 Mar 2012 New trial record